News

A new therapeutic approach in the treatment of multiple sclerosis: Czech investment fund LIFE bioCEEd invests in a project focused on nerve tissue regeneration

LIFE bioCEEd has announced its entry into the development of a novel therapeutic approach for multiple sclerosis, which has the potential to fundamentally change the current treatment paradigm for this chronic disease. The project originated at the Medical University of Gdańsk in Poland as part of research led by neuroscientist Dr. Rutkowska, whose work has long focused on nerve tissue regeneration and the mechanisms of brain damage in neurological diseases. Multiple sclerosis is a chronic autoimmune disease in which the immune system attacks the brain and spinal cord. A key consequence is dam